Maintenance & Repair in Massachusetts

Tegra Medical is a global contract manufacturer specializing in end-to-end production of medical devices. Headquartered in Franklin, Massachusetts, with manufacturing facilities across the United States, Costa Rica, Switzerland, and Asia, the company employs over 1,000 people. Tegra Medical delivers comprehensive manufacturing solutions including design, prototyping, precision production, assembly, packaging, and sterilization for complex metal and plastic components. The company serves multiple therapeutic areas including oncology, orthopedics, cardiology, minimally invasive surgery, ophthalmic, women's health, drug delivery, and robotic-assisted surgery applications. Advanced manufacturing capabilities include Swiss machining, multi-axis milling, injection molding, wire grinding, and precision finishing. Tegra Medical maintains ISO 13485 certification and FDA registration, supported by rigorous quality management systems. The company also operates Quick Wire & Tubing, an e-commerce platform offering in-stock and custom wire, tubing, and secondary processing services for medical device development and prototyping.

Riverside Medical Packaging Co. Ltd. is a UK-based contract packaging and fulfillment specialist serving the healthcare, medical device, veterinary, nutrition, and supplement sectors. The company provides medical packaging consumables (peel pouches, sachets, bags, medical blisters, lids), packaging equipment (ultrasonic cleaning, contract packing, and sealing systems), and comprehensive contract packaging services. Core capabilities include twelve ISO-certified cleanroom cells for cleaning, molding, assembly, and packing of medical devices. Services span blister packing, pouch packaging, product assembly, and medical device packing. Additionally, the company offers custom fulfillment solutions encompassing project management of packaging design, cleaning verification, packaging validation, stability testing, and sterilization validation. Riverside was acquired by Sterimed in June 2024, a global leader in medical packaging. The company holds ISO 13485 (medical device quality management) and ISO 14001 (environmental management) certifications. Manufacturing capabilities include custom packaging machine design and production, demonstrated by development of face shield manufacturing equipment during COVID-19. The company operates a 16,000 sq ft custom-built facility with expansion capacity, serving complex medical device manufacturers and brand developers requiring regulatory-compliant packaging solutions.

Ranfac Corp. is an ISO 13485:2016-certified Contract Development and Manufacturing Organization (CDMO), Original Equipment Manufacturer (OEM), and Contract Manufacturing Organization (CMO) specializing in custom Class I and Class II single-use hypodermic-based medical devices. Founded in 1888 and based in Avon, Massachusetts, Ranfac operates a vertically integrated 40,000 sq ft facility that manages all production stages in-house: metal machining (12 specialized processes including CNC, laser welding, electropolishing), polymer injection and insert molding (Class 8 cleanroom), cleaning and passivation, cleanroom assembly (Class 7 ISO), and EO sterilization via exclusive STERIS partnership. The company serves minimally invasive surgery access devices, biopsy and aspiration systems, orthobiologics delivery cannulas, interventional radiology components, hematology devices, and general surgery instruments. Ranfac supports low minimum order quantities and scales from prototype to 500K+ units annually. MDSAP, EU MDR, and FDA registered, enabling simultaneous access to seven export markets.

Alden Medical is a comprehensive blending, packaging, and distribution partner with 20 years of experience manufacturing liquid chemicals for the medical industry. The company specializes in the design, formulation, and manufacture of private-label custom formulations, serving clients from pilot batches to full-scale production. The facility is FDA and EPA registered, qualifying it to handle diverse products and chemistries across multiple regulatory frameworks. Core product lines include peracetic acid and glutaraldehyde-based high-level disinfectants, endoscopic detergents, and hand care products. Alden's team of dedicated chemists and chemical engineers focuses on creating new formulations and improving existing technologies. The company serves both small businesses and Fortune 500 manufacturers, offering expertise in product design, development, and validation throughout the entire product lifecycle. Manufacturing capabilities support both custom formulations and established product lines for disinfection, sterilization support, and ancillary medical care products.

BMP Medical is a contract medical plastics manufacturer specializing in custom injection molding and injection blow molding for OEM medical device companies. Established over 45 years ago, the company operates an 80,000 sq. ft. manufacturing facility in Sterling, Massachusetts, featuring 24 molding machines (including 3 injection blow molding units), an 8,000 sq. ft. ISO Class 8 cleanroom, and 30,000 sq. ft. of warehouse space. BMP Medical offers comprehensive services including design and development, expert engineering consultation, precision manufacturing, cleanroom assembly, sterile packaging, process validation (IQ/OQ/PQ), and in vitro diagnostic (IVD) component manufacturing. The company is ISO 13485:2016 certified, FDA registered, and cGMP compliant. Core capabilities include plastic injection molding, injection blow molding, cleanroom Class 7 and Class 8 manufacturing, custom assembly, and private-label packaging solutions. BMP Medical serves pharmaceutical packaging, medical device component, and diagnostic component markets, with an average OEM partnership duration of 10 years. The company emphasizes collaborative, long-term partnerships and flexibility in scaling production for regulated medical devices and diagnostic equipment.

UFP MedTech is a full-service medical device contract manufacturer and packaging solutions provider specializing in single-use devices, sterile packaging, and protective components for medical applications. The company designs, develops, and manufactures thermoplastic and foam-based medical device components, sterile barrier packaging, protective housings, surgical draping systems, patient transfer and support surfaces, and fluid control pouches. Primary markets include infection control, protective packaging, wound care, diagnostics, wearables, interventional and surgical devices, therapeutics, and surfaces and support equipment. UFP MedTech operates FDA-registered cleanroom manufacturing facilities across multiple US locations (Chicopee MA, Grand Rapids MI, Newburyport MA, Georgetown MA) and internationally (Costa Rica, Dominican Republic, Mexico, Ireland, Puerto Rico, Singapore). The company manufactures Class I, II, and III medical devices and holds ISO 13485 certification and FDA registration. Core manufacturing capabilities include precision thermoplastic injection molding, compression molding, thermoforming and heat sealing, cut-and-sew fabrication, rapid prototyping and tooling, and supply chain management. Product lines include FlexShield® TPU pouches for orthopedic implants and surgical instruments, BioShell® bioprocess bag containers, foam and thermoplastic components for implantable devices, catheter and guidewire packaging, and customized medical device packaging solutions. The company was founded in 1963 as United Packaging Corporation and has grown through strategic acquisitions of specialized manufacturers including Dielectrics (2018), Contech Medical (2021), DAS Medical (2021), Advant Medical (2022), AJR Enterprises (2024), Welch Fluorocarbon (2024), Marble Medical (2024), AQF Medical (2024), and most recently UNIPEC and TPI (2025).

Boston MedTech Advisors (BMTA) is a regulatory and business consulting firm serving the medical technology industry. Founded in 2006, the firm provides strategic advisory services to established and emerging medtech companies, healthcare providers, entrepreneurs, and investors. BMTA's service portfolio includes market analysis and business strategy development, business development and licensing support, regulatory affairs and quality assurance consulting, clinical study design and management, pricing and reimbursement strategy formulation, and investment support services. The firm leverages over 100 combined years of medtech industry experience to guide clients through complex regulatory, commercial, and market entry challenges. BMTA works with companies across the full product development lifecycle—from early-stage innovation through market launch and post-market compliance. The firm serves as an integrative consulting partner, addressing multiple business elements simultaneously to accelerate time-to-market while maintaining quality and regulatory integrity. BMTA is well-positioned to advise on FDA regulatory pathways, reimbursement strategies, clinical evidence generation, and business model development for a broad range of medical devices and technologies.

Boyd Biomedical is a biomedical device commercialization partner specializing in the design, manufacturing, and market launch of innovative medical devices. The company serves medical device innovators, startups, and established manufacturers seeking end-to-end support from concept through commercialization. Boyd Biomedical operates through three integrated service lines: Design by Boyd transforms complex biomedical concepts into manufacturable, market-ready devices with superior functionality and intuitive user experiences; Build by Boyd delivers consistent manufacturing quality at competitive costs, supporting both first-product launches and established product scaling; and Launch by Boyd provides strategic positioning and brand development for medical devices targeting investors, clinicians, procurement teams, and patients. The company functions as a partner to biomedical innovators navigating regulatory strategy, design controls, manufacturing scale-up, and market positioning. Boyd Biomedical provides expert analysis and actionable insights through its Knowledge Center, offering case studies, articles, videos, and interviews with founders and executives who have successfully brought breakthrough innovations to market. The firm addresses the critical execution gap between innovation and successful commercialization, positioning itself as a strategic partner for medical device companies seeking to improve their odds of market success and regulatory approval.

TransMedics Group, Inc. is a medical technology company headquartered in Andover, Massachusetts, specializing in organ preservation and transplantation. The company manufactures the Organ Care System (OCS)—an FDA-approved, portable ex vivo perfusion platform that maintains donor organs in a near-physiologic state outside the body. TransMedics offers specialized OCS systems for lung, heart, and liver transplantation, addressing critical limitations of traditional cold storage by reducing ischemic injury, improving organ viability assessment, and enabling long-distance organ retrieval. The company also operates the National OCS Program (NOP), providing comprehensive end-to-end technology and clinical support services to transplant centers, including organ procurement logistics, clinical expertise, and resource optimization. Founded in 1998, TransMedics went public in 2019 and has established itself as a leader in transforming transplant outcomes for patients with end-stage organ failure.

PHASE(n) is a Boston-based contract manufacturing and product development partner specializing in medical device design, process optimization, and second-source manufacturing. The firm provides extended R&D capability to medical device OEMs, supporting projects from concept through manufacturing scale-up. Core competencies include new product design, prototype development, process improvement, quality engineering, and cleanroom assembly. PHASE(n) has documented experience with RF electrodes, powered arthroscopic instruments, and sterile single-use and reusable medical accessories. The company emphasizes collaborative partnerships, cost containment, quality assurance, and accelerated scaling for growing medical device businesses. Services are structured to augment in-house R&D teams without requiring full-time headcount additions.

Micron Solutions Inc. is a publicly traded contract manufacturing organization headquartered in Fitchburg, Massachusetts, specializing in precision-engineered components for the medical device, defense, and life sciences markets. Founded in 1978 and evolved from Arrhythmia Research Technology, Inc., the company operates a 120,000 square-foot ISO 13485-certified manufacturing facility offering integrated services including precision machining, thermoplastic injection molding, mold making, and production of silver-plated medical sensors for disposable electrodes. The company provides value-added finishing services such as pad printing, ultrasonic welding, stamping, and laser marking. Micron Solutions serves orthopedic implant manufacturers, diagnostic test kit producers, drug delivery device makers, and life sciences companies, positioning itself as a comprehensive manufacturing partner capable of handling projects from concept through production while maintaining FDA registration and quality standards.

Product Resources is a US-based contract engineering and manufacturing company specializing in complex scientific instrumentation, medical devices, and industrial automation. Founded in 1979 and based in Newburyport, Massachusetts, the company provides end-to-end design and manufacturing services including product design, prototype development, design for manufacturability, regulatory compliance, pilot production, and full-scale manufacturing with assembly and testing. The company is FDA-registered and ISO 13485:2016 certified for medical device manufacturing, with additional ISO 9001:2015 certification and specialized expertise in design and manufacturing for explosive atmospheres (UL913, ATEX). Product Resources has manufactured diverse products including microfluidic dispensing systems, dental laser instruments, surgical robot navigation systems, pharmaceutical process equipment, cryogenic sample preparation devices, automated chemistry lab equipment, and control systems for medical devices. The company serves OEMs, medical device manufacturers, and technical startups across North America, Europe, and Japan, with approximately half of products exported globally.

TESco Associates, Inc. is a specialized contract manufacturer and research & development partner for bioabsorbable medical devices and implants. Founded in 1980 and headquartered in Tyngsborough, Massachusetts, the company operates a 15,000 sq. ft. cGMP-compliant facility with 12 Class 10,000 cleanroom suites. TESco provides comprehensive services across the medical device lifecycle: product development support, material selection and custom polymer formulation, mold design and fabrication, and manufacturing problem-solving from concept through clinical trials and commercial production. The company has developed proprietary polymer processing techniques for injection molding, extrusion, and specialty material blending, with expertise in low molecular weight loss and residual monomer control. TESco's portfolio includes bioabsorbable orthopedic implants, surgical screws, plates, clips, and interference devices. The firm serves as an outsourced partner for medical device companies requiring specialized expertise in bioabsorbable polymeric systems and has supported development of hundreds of bioabsorbable products.